Introduction {#s0001}
============

Medical overuse means services that are more harmful than beneficial, does not seem to increase the quality and quantity of life, impose excessive cost on the patients and their healthcare system, has low quality and if the patient has enough information, he or she will not ask for it.[@cit0001],[@cit0002]

Overuse can take place in different areas including medication, test, or procedure.[@cit0003] Recent studies have shown that overuse of tests and treatments can lead to serious consequences on patients in six domains including physical, psychological, social, financial, treatment burden, and dissatisfaction with healthcare.[@cit0004] Medical overuse can delay access to the goals of health systems-improved health, responsiveness, financial risk protection, and efficiency-by increasing cost and decreasing the quality of medical care.[@cit0005]

Given the fact that medical overuse is one of the problems that can make system performances problematic, its identification is of great importance for a health system.[@cit0006] Also, overuse in medical care is one of the obstacles to achieving universal health coverage (UHC).[@cit0007] If we want to achieve better UHC, we need to be able to manage costs, and one of the most important tasks in this direction is to reduce overuse in medical services.[@cit0008],[@cit0009]

Over the years, many efforts have been made to identify overuse in medical care across health systems around the world.[@cit0010],[@cit0011] In Iran, as in many other countries, there is little evidence about the amount of medical overuse in the healthcare system.[@cit0001] So, the identification of medical overuse is an essential issue for the Iranian healthcare system and also helps health policymakers, health and medical managers, researchers, general practitioners, patients, and their families to cope with harms, costs, and quality of services. Ultimately, identifying the overuse of medical care can bring our health system to balance in the right use of services. Thus, the objectives of this systematic scoping review were 1) to review the literature on the overuse of medical care, (2) to identify the areas in which the overuse of medical care take placed (3) to determine the rate of overuse of medical care in the Iranian healthcare system and its drivers and (4) to identify the interventional studies in clinical and administrative level for decreasing the rate of overuse.

Materials and Methods {#s0002}
=====================

We conducted a systematic scoping review on medical overuse following the PRISMA-ScR checklist ([[supplementary material](http://www.dovepress.com/get_supplementary_file.php?f=262908.doc)]{.ul}) and the five stages outlined in the Arksey and O'Malley framework.[@cit0012] The review protocol was registered in PROSPERO before starting our study (registration no. CRD42017075481) and published in BMJ Open journal.[@cit0001]

Stage 1: Identifying Research Questions {#s0002-s2001}
---------------------------------------

The following questions guided this scoping review of medical overuse in the Iranian healthcare system: How much literatures have dealt with this issue in the Iranian healthcare system? Which area does medical overuse occur? What is the rate of medical overuse in the Iranian healthcare system?

Stage 2: Identifying Relevant Studies {#s0002-s2002}
-------------------------------------

All original articles that investigated the overuse in medical care were included in the study. Of these, only studies were included those have addressed overuse in the Iranian healthcare system. All the included studies were limited in English and Farsi languages. Articles were excluded if the researchers did not have access to the Full-text.

We searched six databases including PubMed, Web of Science, Embase, Scopus, Cochrane and Scientific Information Database (SID) without a time limit until the end of 2018 (31 December 2018). We also contacted the authors of included studies and use reference tracks to get the articles we probably did not find in the search. We used a set of Medical Subject Headings (MeSH) terms and free terms to maximize the sensitivity of the search. For more information on search strategy, see study protocol at: [<https://bmjopen.bmj.com/content/8/4/e020355#ref-17>]{.ul}.[@cit0001] After the article was finished and before the article was published, we searched the PubMed database again and updated our results until July 1, 2020. Details about search strategy are provided in the [[supplementary material](http://www.dovepress.com/get_supplementary_file.php?f=262908.doc)]{.ul}.

Stages 3 and 4: Study Selection and Data Charting Process {#s0002-s2003}
---------------------------------------------------------

After the search was completed, duplicate records were removed. Then, two reviewers screened the records based on the title, abstract and full text, and extracted the data about authors, publication year, type of study, study population, type of service, clinical area, and overuse rate or range. All potential disagreements in each level of study were resolved by consensus with a third researcher.

Stage 5: Summarizing Results {#s0002-s2004}
----------------------------

We categorized the results of the included studies based on publication year, clinical area, type of service (treatment and diagnostic area), and range or rate of overuse.

Results {#s0003}
=======

Initially, a total of 4179 records were screened. After removing duplicates, 3023 records were considered for eligibility. Of these, 41 studies were included. The study selection process is outlined in the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) diagram ([Figure 1](#f0001){ref-type="fig"}).Figure 1Study flow diagram.

Most studies were published in English (78.04%). Included studies published between 1975 and 2019. Most studies were published in 2014 (25%), 2012 (15%) and 2011 (12.5%). Also, in terms of design, 38 were cross-sectional, and three RCT studies. The summary characteristics of the included studies are shown in [Table 1](#t0001){ref-type="table"}. Table 1The Summary Characteristics of the Included StudiesAuthorsYearLanguageStudy DesignSample SizeAhmadi et al[@cit0013]2006FaCross-Sectional400Ahmadizar et al[@cit0014]2011EnCross-Sectional4,456,755Amidi et al[@cit0015]1975EnCross-Sectional40Alavi et al[@cit0016]2014EnCross-Sectional410Alavi et al[@cit0017]2014EnCross-Sectional8586Azami et al[@cit0018]2006FaCross-Sectional150Ahmadi et al[@cit0019]2014EnCross-Sectional1309Alizadeh et al[@cit0020]2012EnRCT200Bijani et al[@cit0021]2014EnCross-Sectional1543Hatam et al[@cit0022]2011EnCross-Sectional1000Khakhshour et al[@cit0023]2011FaCross-Sectional292Refahi et al[@cit0024]2016EnCross-Sectional115Sobhani et al[@cit0025]2001FaCross-Sectional4750Saadat et al[@cit0026]2008EnCross-Sectional1650Sadeghi et al[@cit0027]2015FaCross-Sectional2105Taghizadeh et al[@cit0028]2013EnCross-Sectional234Zargar et al[@cit0029]2014EnCross-Sectional400Vessal et al[@cit0030]2011EnCross-Sectional155Bakhit et al[@cit0031]2014EnCross-Sectional270Bayani et al[@cit0032]2014FaCross-Sectional400Bilehjani et al[@cit0033]2017EnCross-Sectional620Davoodian et al[@cit0034]2012EnCross-Sectional206Eini et al[@cit0035]2012FaCross-Sectional100Fard et al[@cit0036]2001EnCross-Sectional279Forouzanfar et al[@cit0037]2014EnCross-Sectional2607Ghadimi et al[@cit0038]2011EnCross-Sectional2041Ghaffarpasand et al[@cit0039]2011EnCross-Sectional1679Ghazizadeh et al[@cit0040]2009EnRCT60Jame et al[@cit0041]2014EnCross-Sectional400Moussavi et al[@cit0042]2015EnRCT100Khaji et al[@cit0043]2006EnCross-Sectional1209Meidani et al[@cit0044]2017FaCross-Sectional361Meidani et al[@cit0045]2016EnCross-Sectional384Memari et al[@cit0046]2012EnCross-Sectional345Moghimi et al[@cit0047]2008FaCross-Sectional1220Mohammadi et al[@cit0048]2016EnCross-Sectional279Mokhtari et al[@cit0049]2014EnCross-Sectional1219Nikbakhsh et al[@cit0050]2010EnCross-Sectional498Raji et al[@cit0051]2018EnCross-Sectional112Paydar et al[@cit0052]2012EnCross-Sectional5091Saboor et al[@cit0053]2019ENcross-sectional1591

The result categorized into two distinct clinical areas: treatment (18 articles), and diagnostic (23 articles) area. Unnecessary overuse of Antibiotics, MRI, and CT-scan were the most reported topics. The ranges of their overuse proportion were as follows; Antibiotic (31 to 97%); MRI (33 to 88%), and CT-scan (19 to 50%). Among the studies in the area of treatment, the most studied were antibiotics (7 studies, 38.8%), and three studies (16.6%) did not compare the results with any other standard. Also, among the studies in the area of diagnosis, the most studied were related to MRI (4 studies, 17.3%), and CT (4 studies, 17.3%), and three studies (13%) did not compare the results with any other standard. For more details see [Tables 2](#t0002){ref-type="table"} and [3](#t0003){ref-type="table"}. Table 2The Characteristics of Included Studies in Treatment AreaAuthorsClinical DomainSubjectThe Ranges of Overuse Proportion (%)StandardAmidi et al[@cit0015]TreatmentAntibiotic92.5Clinical guidelineKhakhshour et al[@cit0023]TreatmentAntibiotic70Clinical guidelineAlavi et al[@cit0016]TreatmentAntibiotic41.4Clinical guidelineVessal et al[@cit0030]TreatmentAntibiotic31.6American Society of Hospital Pharmacists (ASHP) guidelinesHatam et al[@cit0022]TreatmentAntibiotic98ASHPAlavi et al[@cit0017]TreatmentAntibiotic44Mangram's guidelineTaghizadeh et al[@cit0028]TreatmentAntibiotic61NRAhmadizar et al[@cit0014]TreatmentDrug-Drug Interaction0.77National guidelineBijani et al[@cit0021]TreatmentPolypharmacy16.5--35.1National guidelineSobhani et al[@cit0025]TreatmentPolypharmacy88NRAhmadi et al[@cit0013]TreatmentPolypharmacy39.6National guidelineAzami et al[@cit0018]TreatmentBlood transfusion26.8Scientific criteriaAhmadi et al[@cit0019]TreatmentIntravenous AcetaminophenNRNRAlizadeh et al[@cit0020]TreatmentHeparinNRHeparinization protocolGhadimi et al[@cit0038]TreatmentPrescribing pattern30Beers criteria and WHO indicatorsGhazizadeh et al[@cit0040]TreatmentGnRH antagonistNRStudy protocolMemari et al[@cit0046]TreatmentPsychotropic medication80DSM-IV-TR criteriaSaboor et al[@cit0053]TreatmentInappropriate medication26Beers' criteria 2012[^1] Table 3The Characteristics of Included Studies in Diagnostic AreaAuthorsClinical DomainSubjectThe Ranges of Overuse Proportion (%)StandardRefahi et al[@cit0024]DiagnosticMRI45.2Local guidelineZargar et al[@cit0029]DiagnosticMRI46.5Clinical guidelineSaadat et al[@cit0026]DiagnosticMRI82.8Clinical guidelineSadeghi et al[@cit0027]DiagnosticMRI76Clinical guidelineBakhit et al[@cit0031]DiagnosticDiagnosis of dizzinessNRClinical guidelineBayani et al[@cit0032]DiagnosticClinical diagnosis and candida cultureNRClinical guidelineBilehjani et al[@cit0033]DiagnosticErythrocyte Sedimentation Rate (ESR)NRNRDavoodian et al[@cit0034]DiagnosticUrinary catheters20.6NREini et al[@cit0035]DiagnosticAntibacterial therapy97Clinical guidelineFard et al[@cit0036]DiagnosticVenous duplex ultrasonography (VDUS)NRScientific criteriaForouzanfar et al[@cit0037]DiagnosticChest X-ray (CXR)7.5Thoracic Injury Rule out Criteria (TIRC)Ghaffarpasand et al[@cit0039]DiagnosticRadiographyNRATLS protocolJame et al[@cit0041]DiagnosticComputed tomography19.8--51.6Glasgow coma scoreMoussavi et al[@cit0042]DiagnosticComputed tomographyNRGlasgow coma scoreKhaji et al[@cit0043]DiagnosticComputed tomography66.5Glasgow coma scoreMeidani et al[@cit0044]DiagnosticComputed tomography14.1ACR criteriaMeidani et al[@cit0045]DiagnosticLaboratory test26.4ACR criteriaMoghimi et al[@cit0047]DiagnosticPreclinical test1.3--9.6NRMohammadi et al[@cit0048]DiagnosticMRI33NICE and AHRQ guidelinesMokhtari et al[@cit0049]DiagnosticVenous thromboembolism (VTE) prophylaxisNRACCP guidelinesNikbakhsh et al[@cit0050]Diagnosticelectrocardiogram (ECG)77.3American Society of Anesthesiologists status (ASA) criteriaRaji et al[@cit0051]DiagnosticPulmonary CT angiographyNRGeneva score and Wells' criteriaPaydar et al[@cit0052]DiagnosticRoutine chest radiography for stable blunt trauma19.8ATLSSalari et al[@cit0062]DiagnosticKnee MRI24National guideline[^2]

Discussion {#s0004}
==========

This systematic scoping review aimed to perform an inclusive search for original studies that report medical overuse in the Iranian healthcare system. Finally, 41 original studies were included in our study, of which 18 articles related to the treatment area and 23 articles related to the diagnostic area. Antibiotics and MRI were the most reported issues in each category where overuse has been reported.

[Tables 2](#t0002){ref-type="table"} and [3](#t0003){ref-type="table"} shows the majority of studies only have focused on the magnitude of unnecessary diagnostic and treatment services. There are only a few interventional studies regarding diagnostic and treatment services. Also, there is not any study regarding unnecessary clinical preventive services like unnecessary check-ups and also unnecessary public health services. Unfortunately, as the Tables show there is not any study at the regional or national level that clarifies the drivers of unnecessary services in Iran and how to address them. To address the shortage of study regarding the interventions for decreasing the overuse rate in Iran we already conducted qualitative research at the national level to clarify the drivers of overuse and strategies for controlling these drivers in Iran. In this qualitative study, we interviewed 21 well respected old hand policymakers and researchers of Iran. After analyzing the interview, our study showed that the main drivers of unnecessary overuse in the Iranian healthcare system are physician, patient, organizational, socio-cultural, market, and mass media factors. Also, a Policy Delphi analysis as part of our national study and based on the key informant's opinion,[@cit0054],[@cit0055] showed that the main interventions for decreasing unnecessary overuse of medical services include; implementing strategic purchasing, active engaging of insurance companies, promoting payment system, use of clinical practice guideline in decision making, and increasing political commitment and reducing conflicts of interest. We are going to publish the results of our study in detail. COVID-19 pandemic has created a golden opportunity for addressing the drivers of unnecessary overuse of medical services by countries because of the three main reasons: 1) There is a shortage of healthcare resources for controlling COVID-19 pandemic and unnecessary services waste the resources 2) Overuses of healthcare services unnecessarily expose the patients and healthy individuals to the virus in outpatient clinics and hospitals, 3) Overuse of medications may suppress the immune response and predispose people to COVID-19 infection. Our preliminary search shows that the COVID-19 pandemic has decreased the use of several clinical interventions in countries[@cit0056],[@cit0057] for example screening tests,[@cit0058] admission and hospitalization,[@cit0059] and elective surgeries.[@cit0060],[@cit0061] Considerable proportions of these clinical interventions are unnecessary. We suggest the Iranian ministry of health to use the golden opportunity of COVOD-19 pandemic to develop national policy and action plans for controlling and preventing unnecessary healthcare services in Iran. These policies will facilitate the controlling of the COVID-19 epidemic and preventing underuse of necessary services during the COVID-19 epidemic and after the end of the epidemic.

Since this study was the first study in this field in Iran, there have been some limitations in conducting the study. One of the limitations has been related to the search strategy and how to search, which has made it difficult to research in this area due to the wide range of keywords. Researchers have tried to cover this limitation as much as possible by selecting multiple keywords, searching multiple databases, and using reference tracking and author contacting. Another limitation is the lack of evidence for some of the purposes of the study. For example, there has been no study on interventions to prevent medical overuse at the regional or national level, and we have limited evidence. However, it is one of the interesting and important results of the study.

Conclusion {#s0005}
==========

Our systematic review shows even so the magnitude of unnecessary overuse of medical services is high but there are only a few interventional studies at the clinical and administrative levels for finding effective methods for decreasing these unnecessary services. Researchers should be encouraged for conducting such researches. It is necessary to be included a section for "Interventional Research" in the action plans we suggest to the ministry of health for controlling and preventing unnecessary healthcare services in Iran.
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